4 ways stem cells could change health and medicine – Genetic Literacy Project
|
4 ways stem cells could change health and medicine
Genetic Literacy Project Clinical applications of MSCs: Mesenchymal stem cells, the major stem cells for cell therapy, have been used in the clinic for approximately 10 years…Other promising therapeutic avenues for MSCs include the treatment of autoimmune disease, … Global Regenerative Medicine Market to Reach US$6.5 bn by 2019, Propelled by Increasing Demand for Tissue …Satellite PR News (press release) |
Genetic Engineering & Biotechnology News |
Immunotherapy Coalesces on Platelets as Drug Delivery Mechanism
Genetic Engineering & Biotechnology News Maintaining hemostasis (stop bleeding) is the main function of thrombocytes—commonly referred to as platelet. Yet, what if these cells could be engineered to carry anti-cancer drugs to wipe out those microtumors? Well, scientists at the University of … |
BioPharma-Reporter.com |
Entering the RAT race? FDA issues instructions for new cell therapy designation
BioPharma-Reporter.com The 21st Century Cures Act, signed into US law in December by former President Obama, introduced the Regenerative Advanced Therapy (RAT) designation offering personalised medicine makers an “efficient development program for, and expedite review … |
BioPharma-Reporter.com |
Entering the RAT race? FDA issues instructions for new cell therapy designation
BioPharma-Reporter.com The 21st Century Cures Act, signed into US law in December by former President Obama, introduced the Regenerative Advanced Therapy (RAT) designation offering personalised medicine makers an “efficient development program for, and expedite review … |
Scicasts (press release) (blog) |
CRISPR Meets Single-Cell Sequencing in New Screening Method
Scicasts (press release) (blog) Vienna, Austria (Scicasts) — Genome editing using CRISPR/Cas9 “gene scissors” is a powerful tool for biological discovery and for identifying novel drug targets. In pooled CRISPR screens, a large number of cells are edited simultaneously using CRISPR … |
Seeking Alpha |
The data suggest Asterias’ embryonic stem cell-based therapy may improve motor function.
FierceBiotech Asterias Biotherapeutics has posted data from a phase 1/2a trial of its embryonic stem cell-based therapy. After six months, motor levels of all five evaluable patients who received a 10-million-cell dose have improved. Fremont, California-based … Spinal cord injury patients continue to improve following treatment with Asterias Bio’s AST-OPC1 cells; shares ahead …Seeking Alpha |